Delivery Order SPE2DB22D3301-SPE2DB24FY0LC
Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 unit capsules of the medication Pertzye DR, a pancreatic enzyme replacement therapy, at a firm fixed price of $10,241.07. The contract has an ultimate completion date of May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 16,000 units of Pertzye capsules (pancrelipase 16,000 USP units) valued at $8,939.24 under a firm fixed price contract. This non-set-aside award, issued on August 28, 2025, with completion targeted for August 29, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $4,464.24 firm fixed price delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Pertzye on June 9, 2025, with an ultimate completion date of June 10, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of 24,000 unit capsules of Pertzye (an oral enzyme replacement therapy) with a contract value of $19,766.11 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for 16,000 units of PERTZYE DR, a prescription medication, with a potential value of $5,826.78 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, and it is not designated as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 24,000 units of PERTZYE DR 24,000 UNIT CAPSULE UU 80S, a pharmaceutical product. The contract has a firm fixed price of $7,757.79 and an ultimate completion date of June 26, 2025. The contract is not set aside and was awarded on June 25, 2025. Amerisourcebergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,242.46, is for the delivery of 24,000 units of the prescription medication PERTZYE DR 80S. The contract is a firm fixed-price, non-set-aside award with a performance period through July 2025. Amerisourcebergen also holds a significant Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Pirfenidone 267 mg capsules, with a ceiling value of $22,963.58 and a completion date of May 29, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,264.84, is for the delivery of 36,000 unit capsules of a pharmaceutical product over a period ending on July 14, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PYLERA CAPSULE UU 120S. The $5,382.01 firm-fixed-price contract has an ultimate completion date of August 15, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...